Macrogenics (MGNX) Revenue (2012 - 2026)

Macrogenics (MGNX) has 15 years of Revenue data on file, last reported at $20.8 million in Q1 2026.

• Revenue for Q1 2026 came in at $20.8 million, up 57.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $157.1 million (down 6.05% YoY), and the FY2025 annual result was $149.5 million, changed 0.31% from the prior year.
• Revenue declined to $20.8 million in Q1 2026 per MGNX's latest filing, from $41.2 million in the prior quarter.
• Over five years, Revenue peaked at $110.7 million in Q3 2024 and troughed at $3.3 million in Q2 2024.
• A 5-year average of $32.0 million and a median of $22.2 million in 2025 frame the typical range for Revenue.
• The sharpest annual moves came in 2023 and 2024: Revenue slumped 85.33% in 2023, then surged 964.81% in 2024.
• A 5-year view of Revenue shows it stood at $73.1 million in 2022, then tumbled by 85.33% to $10.7 million in 2023, then surged by 273.13% to $40.0 million in 2024, then gained by 3.07% to $41.2 million in 2025, then sank by 49.61% to $20.8 million in 2026.
• Business Quant data shows MGNX's Revenue at $20.8 million in Q1 2026, $41.2 million in Q4 2025, and $72.8 million in Q3 2025.